Audrey Tseng, Deputy Chairman of PwC Taiwan with PwC Partners Lily Wong and Andy Chang, delve into factors behind the booming pharma and biotech…

Tom Reeves of Interface Biologics (IBI) offers his input about the company’s roadmap towards commercialization, as well as IBI’s differentiation…

Investissement Québec is a public corporation whose mission is to contribute to Québec’s economic development. Investissement Québec’s project…

Charles River is the fifth largest CRO globally and the Canadian affiliate is the largest preclinical organization worldwide. Glenn Washer talks to us…

James Wang, Country Managing Partner of Ernst & Young Taiwan explains why Taiwan’s DIG (Diversify-Innovative-Globalize) strategy is crucial for…

Michael Chiang, the Executive President of Panion & BF Biotech speaks about the incredible growth of the company over the past year, what has…

Wayne Samuels, partner at PwC Canada, discusses the most pressing issues in the country’s healthcare system and pharmaceutical industry, and…

The CEO of OBIO discusses Ontario’s challenges and opportunities in life sciences, highlighting some of the key initiatives that the organization is…

Warren Shapiro, manager of the North American division of Brunel’s life science sector, offers his insights into Canada’s immense human resources…

Mario Piccinin and Lara Iob of EY Canada discuss some of the key trends of the country’s biotech industry and the affiliate’s dedication to…

The president of Biotalent Canada discusses the advantages of being wholly aligned with the government, why the BioTalent is a necessary link between…

The president & CEO of CQDM discusses her vision of how CQDM’s activities can have a direct impact on the development of safer and more…